ARTICLE | Company News
Depomed, New River deal
June 13, 2005 7:00 AM UTC
The companies partnered to develop extended-release formulations of up to three NRPH compounds using DEPO's Gastric Retention oral drug delivery technology. DEPO will be responsible for feasibility st...